C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 1 463.5 INR 0.98% Market Closed
Updated: Jun 1, 2024
Section:
 

Relative Value

The Relative Value of one CONCORDBIO stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 463.5 INR, Concord Biotech Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CONCORDBIO Relative Value
HIDDEN
Unlock
Worst Case
Base Case
Best Case

Valuation Multiples

9.9
P/S
P/S
Price to Sales
9.9
vs History
54
vs Industry
15
Median 3Y
9.8
Median 5Y
9.8
Industry
2.4
Forward
15.1
More Details
33.8
P/E
P/E
Price to Earnings
33.8
vs History
54
vs Industry
14
Median 3Y
33.5
Median 5Y
33.5
Industry
22.4
Forward
49.6
More Details
62.2
P/OCF
P/OCF
Price to OCF
62.2
vs History
45
vs Industry
6
Median 3Y
61.6
Median 5Y
61.6
Industry
16.9
More Details
214.7
P/FCFE
P/FCFE
Price to FCFE
214.7
vs History
45
vs Industry
3
Median 3Y
212.6
Median 5Y
212.6
Industry
22.6
More Details
11.3
P/B
P/B
Price to Book Value
11.3
vs History
45
vs Industry
6
Median 3Y
11.2
Median 5Y
11.2
Industry
2
More Details
9.7
EV/S
EV/S
Enterprise Value to Sales
9.7
vs History
54
vs Industry
14
Median 3Y
9.6
Median 5Y
9.6
Industry
2.5
Forward
14.9
More Details
12.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
12.2
vs History
54
vs Industry
16
Median 3Y
12.2
Median 5Y
12.2
Industry
5.1
More Details
25.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
25.1
vs History
63
vs Industry
14
Median 3Y
25.3
Median 5Y
25.3
Industry
13.3
Forward
35.1
More Details
27.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.6
vs History
54
vs Industry
15
Median 3Y
27.4
Median 5Y
27.4
Industry
16.6
Forward
40.6
More Details
61.2
EV/OCF
EV/OCF
Enterprise Value to OCF
61.2
vs History
45
vs Industry
6
Median 3Y
60.6
Median 5Y
60.6
Industry
15.7
More Details
149.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
149.2
vs History
45
vs Industry
3
Median 3Y
147.8
Median 5Y
147.8
Industry
17.7
More Details
12.3
EV/IC
EV/IC
Enterprise Value to IC
12.3
vs History
45
vs Industry
10
Median 3Y
12.2
Median 5Y
12.2
Industry
1.9
More Details

Multiples Across Competitors

CONCORDBIO Competitors Multiples
Concord Biotech Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Concord Biotech Ltd
NSE:CONCORDBIO
153.1B INR 9.9 33.8 25.1 27.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
779.7B USD 21.7 127 62.1 70.7
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 16.9 46.3 34.5 37.9
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
353B USD 4.1 9.2 11.3 14.8
US
Merck & Co Inc
NYSE:MRK
318B USD 5.2 137.9 34.4 56.2
UK
AstraZeneca PLC
LSE:AZN
189B GBP 5.1 38 174.7 278.7
CH
Roche Holding AG
SIX:ROG
184.2B CHF 3.1 16 9.1 10.8
CH
Novartis AG
SIX:NOVN
182.3B CHF 3.4 11.5 8.8 12.8
US
Pfizer Inc
NYSE:PFE
162.4B USD 2.9 -525.6 12.7 20.6
P/E Multiple
Earnings Growth
IN
C
Concord Biotech Ltd
NSE:CONCORDBIO
Average P/E: 52.5
33.8
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
127
364%
DK
Novo Nordisk A/S
CSE:NOVO B
46.3
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.2
-21%
US
Merck & Co Inc
NYSE:MRK
137.9
7 598%
UK
AstraZeneca PLC
LSE:AZN
38
175%
CH
Roche Holding AG
SIX:ROG
16
28%
CH
Novartis AG
SIX:NOVN
11.5
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -525.6
683%

See Also

Summary
CONCORDBIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
CONCORDBIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CONCORDBIO stock valuation using valuation multiples.
Wall Street Estimates
CONCORDBIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CONCORDBIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 142,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.